Cargando…
Utilizing labour and delivery units for remdesivir infusion for high-risk pregnant and postpartum patients with mild-to-moderate disease during a COVID-19 surge
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The Healthcare Infection Society. Published by Elsevier Ltd.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9356568/ https://www.ncbi.nlm.nih.gov/pubmed/35944789 http://dx.doi.org/10.1016/j.jhin.2022.08.001 |
| _version_ | 1784763547084914688 |
|---|---|
| author | Herz-Roiphe, R. Kim, A.Y. Kaimal, A.J. Goldfarb, I.T. |
| author_facet | Herz-Roiphe, R. Kim, A.Y. Kaimal, A.J. Goldfarb, I.T. |
| author_sort | Herz-Roiphe, R. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9356568 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | The Healthcare Infection Society. Published by Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-93565682022-08-07 Utilizing labour and delivery units for remdesivir infusion for high-risk pregnant and postpartum patients with mild-to-moderate disease during a COVID-19 surge Herz-Roiphe, R. Kim, A.Y. Kaimal, A.J. Goldfarb, I.T. J Hosp Infect Practice Points The Healthcare Infection Society. Published by Elsevier Ltd. 2022-11 2022-08-06 /pmc/articles/PMC9356568/ /pubmed/35944789 http://dx.doi.org/10.1016/j.jhin.2022.08.001 Text en © 2022 The Healthcare Infection Society. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Practice Points Herz-Roiphe, R. Kim, A.Y. Kaimal, A.J. Goldfarb, I.T. Utilizing labour and delivery units for remdesivir infusion for high-risk pregnant and postpartum patients with mild-to-moderate disease during a COVID-19 surge |
| title | Utilizing labour and delivery units for remdesivir infusion for high-risk pregnant and postpartum patients with mild-to-moderate disease during a COVID-19 surge |
| title_full | Utilizing labour and delivery units for remdesivir infusion for high-risk pregnant and postpartum patients with mild-to-moderate disease during a COVID-19 surge |
| title_fullStr | Utilizing labour and delivery units for remdesivir infusion for high-risk pregnant and postpartum patients with mild-to-moderate disease during a COVID-19 surge |
| title_full_unstemmed | Utilizing labour and delivery units for remdesivir infusion for high-risk pregnant and postpartum patients with mild-to-moderate disease during a COVID-19 surge |
| title_short | Utilizing labour and delivery units for remdesivir infusion for high-risk pregnant and postpartum patients with mild-to-moderate disease during a COVID-19 surge |
| title_sort | utilizing labour and delivery units for remdesivir infusion for high-risk pregnant and postpartum patients with mild-to-moderate disease during a covid-19 surge |
| topic | Practice Points |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9356568/ https://www.ncbi.nlm.nih.gov/pubmed/35944789 http://dx.doi.org/10.1016/j.jhin.2022.08.001 |
| work_keys_str_mv | AT herzroipher utilizinglabouranddeliveryunitsforremdesivirinfusionforhighriskpregnantandpostpartumpatientswithmildtomoderatediseaseduringacovid19surge AT kimay utilizinglabouranddeliveryunitsforremdesivirinfusionforhighriskpregnantandpostpartumpatientswithmildtomoderatediseaseduringacovid19surge AT kaimalaj utilizinglabouranddeliveryunitsforremdesivirinfusionforhighriskpregnantandpostpartumpatientswithmildtomoderatediseaseduringacovid19surge AT goldfarbit utilizinglabouranddeliveryunitsforremdesivirinfusionforhighriskpregnantandpostpartumpatientswithmildtomoderatediseaseduringacovid19surge |